BrosMed Medical

BrosMed Medical, founded in 2012, is a specialized manufacturer in the medical devices and equipment sector. The company focuses on the design and production of high-performance interventional medical devices, primarily serving interventional cardiologists, radiologists, and vascular surgeons. By leveraging advanced R&D and world-class manufacturing processes, BrosMed Medical provides critical solutions for angioplasty procedures and other minimally invasive interventions. The firm maintains a strong commitment to innovation, ensuring that its product portfolio meets the rigorous demands of modern endovascular medicine.

The company’s extensive product catalog includes specialized devices such as the Artimes PTCA, Apollo PTCA, and various PTA catheters including the Atropos 0.035, Minerva 0.018, and Polux 0.014 series. Additionally, BrosMed Medical offers high-pressure options like the Hermes NC 0.035, Achilles NC 0.018, and Castor NC 0.014 PTA balloons, alongside the Conger Hydrophilic coated wire and a comprehensive suite of procedural accessories. These products are engineered to facilitate precise clinical outcomes, supported by effective supply chain management and flexible distribution channels that span global markets.

Operating with a workforce of 500-1,000 employees, BrosMed Medical continues to expand its footprint in the Asia-Pacific region and beyond. The organization emphasizes a culture of entrepreneurial growth and technical excellence, driving the development of next-generation medical technology. Meet BrosMed Medical's team to learn about the leadership and operational expertise guiding the company’s strategic initiatives. With a revenue of $51.8M, the firm remains a significant player in the global medical device landscape, consistently delivering high-quality, reliable tools for complex vascular procedures.